Zynerba Press Releases

8 Jun 17 Zynerba Pharmaceuticals Achieves Target Enrollment in Exploratory Phase 2 Trial of ZYN002 in Fragile X Syndrome

1 Jun 17 Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference

9 May 17 Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights

27 Mar 17 Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Operational Highlights

13 Mar 17 Zynerba Pharmaceuticals to Report Fourth Quarter and Full-Year 2016 Financial and Operating Results on March 27, 2017

13 Mar 17 Zynerba Pharmaceuticals Announces Completion of Enrollment for ZYN002 in Two Phase 2 Clinical Trials for Epilepsy and Osteoarthritis

1 Mar 17 Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences

9 Feb 17 Zynerba Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

19 Jan 17 Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock

18 Jan 17 Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock